{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Stanford CME | Stanford Medicine
Stanford Center for Continuing Medical Education
  • Sign In
  • Create New Account
  • Home
  • Live Activities
  • On-Demand
  • Hybrid
  • Podcast
  • RSS
  • Journals
  • Other
  • Activity Calendar
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Sign in with your Stanford ID
Sign in with your email and password | Create new account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ADN
  • APRN
  • ASN
  • ASW
  • AT
  • AUD
  • BA
  • BDent
  • BDS
  • BDSc
  • BM BCh
  • BM BS
  • BM ChB
  • BP
  • Bpharm
  • BS
  • BScPH
  • BSN
  • BSPh
  • BSPT
  • BSRT
  • BSW
  • CCP
  • CCT
  • CFRS
  • Chaplain
  • CNL
  • CNM
  • CNM
  • CNS
  • CPhT
  • CRNA
  • CRNP
  • CTR
  • CVT
  • DC
  • DClinDent
  • DDent
  • DDS
  • DDSc
  • DMD
  • DMSc
  • DNE
  • DNP
  • DNSc
  • DO
  • DP
  • DPM
  • DPT
  • DPTSc
  • DrPH
  • DScD
  • DScPT
  • DSW
  • DVM
  • EdD
  • EMT
  • EMT-P
  • FCPS
  • FRCPS
  • JD
  • L.Ac
  • LCPC
  • LCSW
  • LICSW
  • LMFT
  • LMHC
  • LMSW
  • LNM
  • LPC
  • LPCC
  • LPN
  • LRCPE
  • LRCPSG
  • LRCSE
  • LVN
  • MA
  • MB BCH
  • MB Bchir
  • MB BS
  • MB ChB
  • MBA
  • MBBS
  • MCS
  • MD
  • MD, JD
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, PhD
  • MD, MS
  • MD, MSCE
  • MD, PhD
  • MDCM
  • MDent
  • MDentSci
  • MDS
  • MFA
  • MFT
  • MHPE
  • MLIS
  • Mmed
  • MMilMed
  • MMSc
  • MP
  • MPH
  • Mpharm
  • MPT
  • MS
  • MSc
  • MSc, PhD
  • MScPH
  • MScPharm
  • MSD
  • MSM
  • MSN
  • MSN, FNP-BC
  • MSN, PhD
  • MSPH
  • MSPharm
  • MSPT
  • MSSA
  • MSW
  • ND
  • None
  • NP
  • OD
  • OT
  • Other
  • OTR
  • PA
  • PA-C
  • PD
  • Pharm
  • PharmD
  • PharmDc
  • PhD
  • PsyD
  • PT
  • PT, PhD
  • PTA
  • RCES
  • RCP
  • RD
  • RDA
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RTT
  • ScDPT
  • SLP
  • SMF
  • VMD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

2024 Interstitial Lung Disease Symposium: Understanding Genetic Contributors to ILD (RECORDING)


2024 Interstitial Lung Disease Symposium: Understanding Genetic Contributors to ILD (RECORDING) Banner

  • Overview
  • Faculty
  • Register
  • Support
  • Begin


Date & Location
Monday, November 4, 2024, 12:00 AM - Wednesday, November 3, 2027, 11:59 PM, On Demand

Overview
The 2024 ILD symposium aimed to improve the delivery of early, appropriate, and evidence-based care to the patient and family members with familial pulmonary fibrosis (FPF) and review current available genetic testing. Led by the Stanford Division of Pulmonary, Allergy, and Critical Care, this CME symposium sought to fulfill the need of practicing pulmonologists, primary care physicians, advanced-practice providers, and allied health care practitioners to incorporate knowledge of familial pulmonary fibrosis (FPF) into their comprehensive treatment plan for patients with interstitial lung disease.  A team of multidisciplinary experts addressed genetics's role in diagnosing and treating patients with Interstitial Lung Diseases (ILDs), including the increased risks and comorbidities associated with a diagnosis of FPF.

Registration

  Release Date: November 4, 2024
  Expiration Date: November 3, 2027
  Estimated Time to Complete: 6 hours 
  Registration Fee: $25
*Originally recorded on September 14, 2024

 Click Register (at the top) to complete the registration form and begin the activity.


Credits
AMA PRA Category 1 Credits™ (6.00 hours), AAPA Category 1 CME credits (6.00 hours), ANCC Contact Hours (6.00 hours), Non-Physician Participation Credit (6.00 hours)

Target Audience
Specialties - Critical Care & Pulmonology

Objectives
At the conclusion of this activity, learners should be able to:

  1. List the defining features of the short telomere syndromes in adults with ILD
  2. Identify the genes which should be tested in patients and family members with potential FPF
  3. Describe the clinical prognostic and therapeutic value of genetic sequencing in patients with FPF
  4. Discuss how a diagnosis of FPF may impact outcomes following lung transplantation
  5. Carry out a patient history to screen for FPF

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 6.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Enduring Material for a maximum of 6 ANCC contact hours.  

American Academy of Physician Associates (AAPA) - Live 
Stanford Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This Enduring Material is designated for 6 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  


Additional Information

Cancellations Self-paced Activities: No refunds will be made on cancellation requests after a learner accesses any part of the course content. Any cancellations refunded will less a 20% administrative fee. Please send cancellation requests to [email protected]. 

Stanford University School of Medicine reserves the right to cancel this program; in the event of cancellation, course fees will be fully refunded.


Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For References/Bibliography, click here.

For activity related questions, please contact
     Name: Alyssa Elsey
     Title: Education Events Specialist
     Email: [email protected]

For CME general questions, please contact 
 
   Email: [email protected]



Mitigation of Relevant Financial Relationships


Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

All of the relevant financial relationships listed for these individuals have been mitigated.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Rishi Raj, MD
Director, Interstitial Lung Diseases Program
Clinical Professor, Medicine – Pulmonary & Critical Care Medicine, Stanford University
Co-Course Director, Faculty
Grant or research support-Boehringer Ingelheim Vetmedica GmbH
Joshua James Mooney, MD
Associate Medical Director for Lung and Heart Lung Transplantation
Clinical Assistant Professor, Medicine- Pulmonary & Critical Care Medicine, Stanford University
Course Director, Faculty
Advisor-Imvaria|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lung Bioengineering
Gerald J Berry, MD
Faculty
Stanford University
Faculty
Speakers Bureau-Merck and Company, Inc.
Aglaia de Boer, MD
Clinical Assistant Professor, Medicine- Pulmonary & Critical Care Medicine
Stanford University
Faculty
Nothing to disclose
Tushar Jasubhai Desai, MD
Professor
Stanford Health Care (SHC)
Faculty
Grant or research support-Genentech, Inc.|Grant or research support-Boehringer Ingelheim Vetmedica GmbH (Relationship has ended)|Consulting Fee-YAP Therapeutics
Christine K Garcia, MD, PhD
Professor
Columbia University
Faculty
Paid consultant-Rejuveron Telomere Therapeutics (Relationship has ended)|Paid consultant-Rejuvenation Technologies Inc.
Nicholas H Juul, MD
Postdoctoral Medical Fellow, Medicine - Pulmonary & Critical Care Medicine
Stanford University
Faculty
Nothing to disclose
Ann Noi Chi Leung, MD
Stanford University Medical Center
Faculty
Nothing to disclose
Matthew McCarra, MD
Stanford University
Faculty
Nothing to disclose
Yan Wang, PhD
Instructor
Stanford University
Faculty
Nothing to disclose
Susan Jacobs, RN
Research Nurse Manager, Medicine - Pulmonary and Critical Care Medicine
Stanford University
Faculty, Planner
Nothing to disclose

This CME Activity is supported by an educational grant from United Therapeutics.

2024 Interstitial Lung Disease Symposium: Understanding Genetic Contributors to ILD

INSTRUCTIONS: Please purchase video content to continue. After purchase, please click the "Launch Video" button to begin each presentation. After successful completion of all presentations, click the “Claim CE” button (at the bottom). Attest to your participation, view results, and complete the evaluation. After successful completion, your credit transcript will be available to view and download immediately in MY CE portal.

Purchase
Familial ILD: Current State and Future Directions Module
Dr. Christine Garcia's presentation focuses on the genetic factors linked to pulmonary fibrosis. She highlights that common variants, known as "jellybean variants," such as MUC5B, pose a low penetrance risk in the population. In contrast, rare variants like TERT and KIF15 are significant predictors for individuals with autosomal dominant inheritance. Additionally, telomere length, a useful biomarker, indicates worse survival and increased complications with immunosuppression. 
Purchase
Radiology of Familial ILD Module
Dr. Anne Leung presents on CT techniques for evaluating interstitial lung disease, focusing on familial ILD. She emphasizes the importance of high-resolution CT with thin sections, sharp reconstruction kernels, and low-dose techniques. The discussion includes various CT protocols and their trade-offs. She covers CT patterns associated with ILD, and highlights studies on familial ILD's radiologic manifestations. She also discusses case examples related to different genetic mutations. 
Purchase
What Genetics of ILD Tells Us About Lung Biology and Vice-versa Module
This presentation by Dr. Tushar Desai covers the pathogenesis of idiopathic pulmonary fibrosis (IPF). He discusses the role of telomeres and telomerase mutations in causing IPF, as well as the potential involvement of epithelial cells, particularly alveolar type 2 cells which act as stem cells. He presents the current model of IPF pathogenesis and also touches on the puzzling role of the MUC5B promoter polymorphism in IPF.  

Purchase
Developing a Drug Treatment for a Genetic Telomeropathy Module
This recording covers research conducted by Dr. Yan Wang. The study aimed to explore the therapeutic potential of inhibiting the enzyme PAPD5 for treating idiopathic pulmonary fibrosis (IPF) and other telomere-related disorders. Key findings included the identification of potent PAPD5 inhibitors that could increase telomerase activity, HDR levels, and telomere length in human embryonic stem cells and IPF patient-derived cells.  
Purchase
Screening and Testing for Familial ILD: Practical considerations Module
Dr. Kaissa De Boer discusses the importance of recognizing familial interstitial lung disease (ILD) and the role of genetic testing and telomere length measurement in managing these patients. She describes how about 20% of ILD cases have a familial component, testing can identify telomerase-related or surfactant protein mutations, and shorter telomeres may affect treatment responses. She illustrates these concepts with two patient cases. 
Purchase
Liver, Bone Marrow and Other Organ Dysfunction in Telomeropathy Related ILD Module
Dr McCarra discusses telomere biology disorders and their manifestations, particularly in relation to interstitial lung diseases (ILDs). He explains the role of telomeres and the consequences of telomere shortening, leading to cellular senescence and associated pathologies. The presentation covers various aspects, including the biology of telomeres, the clinical manifestations of telomere biology disorders across different organ systems, and potential treatment options.  
Purchase
Therapeutic Considerations in Patients with Familial ILD Module
Dr Nicholas Juul discusses therapeutic considerations for patients with familial interstitial lung disease (ILD), focusing on surfactant gene-related mutations and telomere biology-related mutations. Key points included the varying presentations and natural history of surfactant protein mutations, the limited evidence for immunosuppression in these patients, and the potential role of antifibrotic therapy.  
Purchase
Lung Transplant for Familial ILD: Outcomes and Specific Considerations Module
Dr Mooney discusses lung transplantation for patients with familial interstitial lung disease (ILD) and telomere-related disorders. He provides an overview of lung transplant statistics and describes a clinical case of a patient with telomere-related ILD, detailing his medical history, diagnostic findings, and the decision to refer him for lung transplantation. He emphasizes the importance of early referral for transplantation in progressive fibrotic ILD and the risks and outcomes associated. 
Purchase
Case Studies Module
This recording covers case studies of patients with interstitial lung disease (ILD) and short telomeres. They highlight the diverse clinical presentations, radiological findings, and genetic variations associated with telomere-related pulmonary fibrosis. Key topics include the interpretation of telomere length testing, genetic testing results, radiological patterns, histopathological features, treatment considerations, and the potential role of precision therapies targeting telomere biology.
Purchase

 

©2023 Stanford Medicine | Privacy Policy | Terms of Use

Contact Us: [email protected]

StanfordCME Twitter StanfordCME Podcast StanfordCME LinkedIn StanfordCME Youtube